Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

ArchivedNIH

The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)

Jul 18, 2019
Posted
View opportunity →
ArchivedNIH

Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

Jul 18, 2019
Posted
View opportunity →
ArchivedNIH

Comprehensive Alcohol Research Centers (P60 Clinical Trial Optional)

$1,250,000
Award ceiling
Jul 11, 2019
Posted
View opportunity →
ArchivedNIH

NIA Program Project Applications (P01 Clinical Trial Optional)

Jul 11, 2019
Posted
View opportunity →
ArchivedNIH

Molecular Mechanisms of Blood-Brain Barrier Function and Dysfunction in Alzheimer's disease and Alzheimer's related dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)

$4,500,000
Total funding
Jul 10, 2019
Posted
View opportunity →
ArchivedNIH

Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)

Jul 10, 2019
Posted
View opportunity →
ArchivedNIH

Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)

Jul 10, 2019
Posted
View opportunity →
ArchivedNIH

Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed)

$1,750,000
Total funding
Jul 10, 2019
Posted
View opportunity →
ArchivedNIH

Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R01 - Clinical Trials Not Allowed)

Jul 10, 2019
Posted
View opportunity →
ArchivedNIH

Leveraging Big Data Science to Elucidate the Neural Mechanisms of Addiction and Substance Use Disorder (R21 - Clinical Trials Not Allowed)

Jul 10, 2019
Posted
View opportunity →
ArchivedNIH

Mechanisms of Tolerance (R21/R33 - Clinical Trial Required)

Jul 10, 2019
Posted
View opportunity →
ArchivedNIH

Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional)

Jul 10, 2019
Posted
View opportunity →